These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31911262)

  • 1. Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery.
    Patel DM; Thiessen-Philbrook H; Brown JR; McArthur E; Moledina DG; Mansour SG; Shlipak MG; Koyner JL; Kavsak P; Whitlock RP; Everett AD; Malenka DJ; Garg AX; Coca SG; Parikh CR
    Am Heart J; 2020 Feb; 220():253-263. PubMed ID: 31911262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated preoperative Galectin-3 is associated with acute kidney injury after cardiac surgery.
    Wyler von Ballmoos M; Likosky DS; Rezaee M; Lobdell K; Alam S; Parker D; Owens S; Thiessen-Philbrook H; MacKenzie T; Brown JR
    BMC Nephrol; 2018 Oct; 19(1):280. PubMed ID: 30342486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Kim AJ; Ro H; Kim H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Nephrol; 2021; 52(2):119-130. PubMed ID: 33725696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.
    Polineni S; Parker DM; Alam SS; Thiessen-Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Balsam P; Opolski G; Filipiak KJ
    Dis Markers; 2019; 2019():9529053. PubMed ID: 31687050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting.
    Stabler ME; Rezaee ME; Parker DM; MacKenzie TA; Bohm AR; DiScipio AW; Malenka DJ; Brown JR
    Biomarkers; 2019 May; 24(3):268-276. PubMed ID: 30512977
    [No Abstract]   [Full Text] [Related]  

  • 9. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Biomarkers for Risk Stratification of Acute Kidney Injury After Pediatric Cardiac Surgery.
    Greenberg JH; Parsons M; Zappitelli M; Jia Y; Thiessen-Philbrook HR; Devarajan P; Everett AD; Parikh CR
    Ann Thorac Surg; 2021 Jan; 111(1):191-198. PubMed ID: 32283087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
    Rabkin SW; Tang JKK
    Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers associated with 30-day readmission and mortality after pediatric congenital heart surgery.
    Parker DM; Everett AD; Stabler ME; Vricella L; Jacobs ML; Jacobs JP; Thiessen-Philbrook H; Parikh CR; Brown JR
    J Card Surg; 2019 May; 34(5):329-336. PubMed ID: 30942505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
    Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
    J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction.
    Cui Y; Qi X; Huang A; Li J; Hou W; Liu K
    Med Sci Monit; 2018 Jul; 24():5139-5146. PubMed ID: 30039808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
    Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery.
    Lobdell KW; Parker DM; Likosky DS; Rezaee M; Wyler von Ballmoos M; Alam SS; Owens S; Thiessen-Philbrook H; MacKenzie T; Brown JR
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1114-1123.e2. PubMed ID: 29759735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery.
    Machado MN; Nakazone MA; Maia LN
    Rev Bras Cir Cardiovasc; 2014; 29(3):299-307. PubMed ID: 25372901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study.
    Li F; Xu M; Fu M; Cui X; Lian Z; Xin H; Zhou J; Ge J
    BMC Cardiovasc Disord; 2021 Aug; 21(1):396. PubMed ID: 34404341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.